Infertility Worldwide: The Lack of Global Pediatric Andrologists and Prevention by Nicola, Zampieri et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
Chapter
Infertility Worldwide: The Lack
of Global Pediatric Andrologists
and Prevention
Zampieri Nicola, Bianchi Federica, Patanè Simone,
Vestri Elettra and Camoglio Francesco Saverio
Abstract
Andrology is the medical specialty dealing with men’s health and reproductive
system, including the genital, hormonal, reproductive, sexual, as well as psycholog-
ical aspects, from birth to adulthood. Regular andrological checkups are essential
both to reveal possible problems and to receive thorough advice and information so
as to ensure that sexual and reproductive functions are well preserved. Estimates
report that about one in three males suffers from andrological diseases, their rates
varying according to the age: 27–30% of pediatric male subjects have reproductive
and/or sexual conditions. In adulthood, 40% of men are affected by andrological
diseases, in particular infertility and sexual problems. We studied medical literature
about infertility, its prevention, and its treatment; our outcomes were to evaluate
the role of research to prevent infertility especially in pediatric and adolescent age.
The analysis of the data shows that in absolute numbers, the conditions directly
associated with infertility are less studied than the treatment with medically assisted
procreation. This research is intended as a warning to the countries worldwide: all
those involved in the pediatric treatment area should be stimulated to act toward
this goal, and each country should bear the responsibility of promoting and
financing andrological screening campaigns.
Keywords: infertility, varicocele, pediatric, adolescence, undescended testes,
medical-assisted reproduction
1. Introduction
Andrology is the medical specialty dealing with men’s health and reproductive
system, this including the genital, hormonal, reproductive, sexual, as well as psy-
chological aspects, from birth to adulthood. Regular andrological checkups are
essential both to reveal possible problems and to receive thorough advice and
information as to ensure that sexual and reproductive functions are well preserved.
Estimates report that about one in three males suffers from andrological dis-
eases, their rates varying according to the age: 27–30% of pediatric male subjects
have reproductive and/or sexual conditions, especially cryptorchidism, varicocele,
hypogonadism, congenital anomalies of the genitourinary tract, and sexually trans-
mitted diseases. In adulthood, 40% of men are affected by andrological diseases, in
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particular infertility and sexual problems. The main surgically correctable diseases
to prevent hypofertility are varicocele (30%) and undescended testes (<5%) [1–3].
The origin of many of the andrological conditions appearing during adulthood is
to be traced before the age of 18 and sometimes even during gestation. The male
gonad is extremely sensitive to external events even during gestation and soon after
childbirth up until puberty. The andrological evaluation of pediatric patients is
therefore extremely important for the early diagnosis of genital anomalies such as
penile alterations or abnormal positions of the testis; early evaluation is helpful also
to search for risk factors in terms of male general and sexual health.
Andrology greatly trusts primary prevention to reduce the incidence of
andrological diseases and conditions. Clinical studies and primary prevention inter-
ventions in andrology should be focused on the most vulnerable crucial phases of
male gonad development that can be affected by a variety of external agents.
The preservation of the genital and sexual health of young people also means
protecting their fertility, a very important action within the broader scope of the
interventions aimed at reducing the drop in the birthrate affecting modern society.
Despite few exceptions, the prevention and early diagnosis of the andrological
conditions have been neglected worldwide for too long. This has favored an increase
in the incidence and prevalence of diseases that are otherwise easy to prevent and
treat if diagnosed early.
The data collected during screening procedures in young males show that <5%
receive an andrological examination before the age of 20. Female patients of the
same age adhere to gynecological screening tests with decidedly higher rates. A real
“gender discrimination” about prevention [4].
This leads to an increase in undiagnosed andrological diseases that remain so
until adulthood when the treatment becomes more complex for the patient and
more expensive for the national healthcare system.
Therefore, it is necessary to promote awareness on this social issue: undergoing
regular and well-timed andrological checkups is essential for the early diagnosis
of andrological conditions as well as for the general health of men’s sexual and
genital functions.
This point in mind, in order to safeguard the reproductive and sexual health of
young men, the synergic approach involving pediatricians, general practitioners,
doctors at family planning clinics, and andrologists for the adults plays a key role
together with the implementation of territorial networks integrating the know-how
and expertise of all these health professionals.
This is especially true in the extremely vulnerable period of life generally rang-
ing from 11 to 18 years of age, when young male patients experience the transition
to adult life and maturity from the reproductive and sexual point of view.
All this can be achieved also increasing the social awareness on the matter via
systematic information and education of the population thanks to campaigns and
primary prevention interventions. To this end, research and study of andrological
diseases in the pediatric-adolescent patients are crucial, especially research, whose
main aim is to anticipate the treatment of all those conditions that can alter the
fertility potential of men.
These are the grounds for this study, which compares good clinical practices
worldwide for the preservation of male fertility in young patients by comparing the
results with the evidence from the scientific research carried out on the treatment of
male infertility.
In the last 40 years, the number of spermatozoa in the semen of male patients of
childbearing potential has decreased by more than a half [5].
Incorrect lifestyles, pollution, and poor prevention are the main causes of a
dramatical drop in the male fertility rates. According to the latest international
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reports, the rate of male infertility among the couples who seek advice from spe-
cialized centers to bear a child is 30–35%, and age is not the only liable factor;
correctable causes include varicocele, which accounts for 30–35% of cases, and
evidence of previous untreated or poorly followed cryptorchidism (5%) [5–7].
Medically assisted procreation is suggested as one solution to the human and
social problem of sterility. But, as reported by many authors, can assisted procre-
ation be considered as a suitable therapy?
In many countries, assisted procreation is funded from public health insurance.
Without this coverage, it would be used much less frequently. What is then more
important? The treatment of sterility or the increase in the birthrate? The answer to
this question is manifold.
One of the reports by the International Committee for Monitoring Assisted
Reproductive Technology (ICMART) re-established that over 1 million ART cycles
were performed worldwide in 2002, with a progressive increase compared to the
previous years. The progressive increase shows how research and clinical medicine
are drastically moving away from the real investigation of infertility [6–8].
The costs associated with the ART can be divided into direct and indirect costs;
the direct costs, which vary according to the mother’s age, are those necessary to
“guarantee” a pregnancy, from the medically assisted treatment to childbirth. The
indirect costs include the costs directly related to childbirth, to a possibly premature
birth, to twin pregnancies, to the management of any complications, and to the
management of chronic diseases of the newborn child and of the mother as
well [7–9].
Obviously, the average direct cost of each procedure is calculated by dividing the
total number of procedures performed per year by the number of live births. These
costs are country-related, with variations of up to tenfold values; direct ART treat-
ment costs show considerable variations among countries, with the USA standing
out as the most expensive and Northern European countries and Japan as the least
expensive countries. For example, reports show that the costs per live birth are
similar for ages 24 (€17,000) and 33 (€ 18,500), after which they begin to increase,
with the cost per live birth reaching € 54,000 at age 42.
Indirect costs, especially when associated with multiple gestations, vary from
country to country: in 2004 such costs ranged between € 24,377 for a singleton
pregnancy and € 35,042 for a twin pregnancy up to 27 days after birth [6–9].
The first international report on the results of assisted medical procreation
(AMP) was published in Paris in 1991 on the occasion of the 7th World IVF
Congress. From a scientific point of view, the role of international reports is to
monitor the number of procedures as well as to study the efficacy of the treatments
indicated.
Every year the procedure registers are updated. The recorded data show a
constant increase in these procedures with a steady increase in live births. The latest
data, published in 2018 and referring to 2011, show that approximately 1.6 million
procedures were performed with approximately 400,000 births worldwide.
These figures allow to calculate the costs per year for the national healthcare
systems [7–9].
2. Literature searching
This research was performed by taking into consideration two aspects sepa-
rately: infertility and pediatric andrological diseases associated with infertility.
Browsing the most important engines for scientific research (PubMed, Scopus,
Google Scholar), several keywords were considered: infertility, male, semen,
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adolescent, varicocele, undescended testes, cryptorchidism, hormone, and assisted
medical procreation (Table 1).
We searched with association like: adolescent and infertility; varicocele and
semen, etc.
A number of papers and number of the most important associations are
explained in the table.
Some considerations are essential: the literature regarding medically assisted
procreation should be considered only from 1990 onward, and, from a strictly
epidemiological point of view, also for varicocele some distinctions should be made.
Varicocele seems to have a clear phenotypic trend, for which it is possible that in
some countries the prevalence of the disease is lower than in others, justifying a
paucity of literature on this topic. However, when comparing the origin of scientific
publications on pediatric varicocele and cryptorchidism, Europe and North America
cover about 70% of the overall publications worldwide, reaching 80% of the
published literature about infertility and assisted medical procreation. Asia and
Africa, on the contrary, show poor preventive research while favoring the research
on assisted medical procreation.
The analysis of the data offers some interesting insights:
1.Most of the literature on the topics of this research was published after the year
2000, with the two maximum rates of 84 and 79% for medically assisted
procreation. This can be reasonably associated with the widespread use of the
procedures after the 1990s. If such figures are correlated to the other
percentages found, they also show how the focus of scientific research has
slanted toward the treatment of infertility rather than its prevention.
2.In absolute numbers, the conditions directly associated with infertility are less
studied than the treatment with medically assisted procreation.
Group Key Total >2000 % of paper Statistical
comparison per group
1 Infertility-male 46103 26296 (57%) 1/2: p < 0.05
2 Varicocele 5292 2788 (52%) 1/3: p < 0.05
3 Undescended
testes
10245 4250 (41%) 1/3: p < 0.05
4 Assisted
reproduction
25399 20309 (79%) 1/4: p < 0.05
5 V-adolescence/
pediatric age
1396 147 (real pediatric-
adolescent age-range with
follow-up)
776 (55%) 2/5: p < 0.05
6 Infertility-U 1195 676 (56%) 6/3: p < 0.05
7 Infertility-semen 11289 6556 (58%) 1/7: p > 0.05
8 Assisted medical
procreation
6701 5635 (84%) 1/8: p < 0.05
9 Infertility-VAR 2429 1349 (55%) 1/9: p < 0.05
Statistical analysis: Statistical analysis was performed using the student t-test. Significance value was set at p < 0.05.
Associations: varicocele and pediatric age/adolescence; infertility and undescended testes; infertility and varicocele;
statistical comparison between groups: chi-square test comparing number of total paper published and paper
published after 2000 per each -group and sub groups.
Table 1.
Data from the research: number of papers published per disease and with multiple associations.
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3.A comparison between varicocele and cryptorchidism, namely, the two main
male infertility diseases, shows that although varicocele is the first treatable
cause of infertility, it is not as much investigated as cryptorchidism,
accounting for <5% of the curable causes of infertility. From a purely
numerical point of view, cryptorchidism is studied more than varicocele, with
varicocele being more investigated after the year 2000. This means that long-
term studies on varicocele have been done only in the last 20 years.
4.A comparison between group 1 (infertility and male), which is the most
represented in terms of number of publications pre- and post-2000, and all the
other subgroups points out that the “infertility and semen” subgroup is the
only comparable group within the main scope of the survey. This indicates that
most of the studies on male infertility do not investigate the causes leading to
these conditions, because they focus only on their effects
5.The correlation between infertility and varicocele offers some insights: while
in numerical terms, there is little investigation of varicocele in association with
infertility, which is one of its effects; more is studied about its treatment
(surgical treatment, percutaneous treatment, etc.). It is important to report
that since 2000, only 147 papers focused on pediatric-adolescent varicocele
and its management with a long time follow-up (>3 years).
3. Pediatric varicocele
3.1 Focus about pediatric varicocele: the first infertility-related and treatable
andrological disease
About this specific topic, where varicocele is the first treatable cause of infertil-
ity in adulthood, we found that a total of 625 articles was published since 2000,
matching the mentioned criteria; after our selection only 147 articles resulted pro-
viding innovative topics in the pediatric range. As a first consideration, we can state
that most publications concentrate in Europe, Asia, and North America (the USA
being by far the most represented in North America). The percentage of pediatric
works is 27.0% being above average in Europe and North and South America. Asia
has a considerable number of published articles even though the percentage of
pediatric ones is far below average. Africa and Oceania have, respectively, 2 and 1
pediatric articles.
Then we analyzed the main topic and secondary topics of the selected articles.
Prevalence of different categories in each continent was summarized, and the main
subjects for Europe are surgical technique, videolaparoscopy, and diagnosis; for
North America, surgical technique, diagnosis, and endocrinology; and for Asia,
video laparoscopy, endocrinology, and screening.
South America includes 10 articles discussing mainly about fertility and semen
analysis, being the only region in which this topic appears to be central. Africa had
only two publications in the pediatric field, centered on diagnosis and non-
operative treatment. The only pediatric publication published in Oceania was cen-
tered on video laparoscopy.
Overall prevalence of topics in the discussed articles was considered as well, and
we found that in North America and Asia follow-up prevails as a concomitant topic
in many articles, together with complications and relapses. Another topic strongly
represented in these regions is endocrinology. On the other side, Europe maintains
topics that mainly represented surgical technique and videolaparoscopy, accounting
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for about 50% of all topics, and then diagnosis is still present, showing little differ-
ence between main topic and all mentioned topics in the publications.
Eventually, a study of the topics and their prevalence over years was performed
to see the trend of interest. A significant trend in publications could not be evinced,
neither overall nor for single continent. Publication numbers by year underwent
cyclic changes over the last 20 years with a peak in 2008 including 16 publications
about pediatric varicocele.
A natural comment to the number of publication is the fact that pediatric articles,
focusing on pure research, account for <1 third of overall articles about varicocele.
This could be due to the fact that historically varicocele is considered as an adult
pathology; thus not enough interest is found in its pediatric side. Different series of
studies report a higher prevalence of varicocele in adult population than in pediatric
one. However it must be taken into account the lack, in almost all countries, of
pediatric screening programs for varicocele that could give a strong bias about the
exact prevalence of the pathology in pediatric population. Moreover the study of
varicocele related to infertility is considered more imminent in adult life, when
looking for paternity that during adolescence when study of future fertility may seem
premature. In fact many studies on varicocele are performed retrospectively when
the patient in adult life has not the possibility to become father (see table).
Concerning the major topics of the publications, in the most represented conti-
nents, the first interest of research is surgical technique, may it be traditional
surgery or videolaparoscopy technique. We can also see that in the first three
majorly represented topics and figures either screening or diagnosis this reflects an
attention of research to detection and treatment rather than to follow-up or pre-
vention of infertility. Other topics were only minimally represented. It must be
stated that healthcare organization of each single country may influence the topics
and publications: in fact screening would not be so represented in countries with
private healthcare or, on the other hand, countries with increased population den-
sity would feel less important the problem of infertility. The prevalence of varico-
cele according to the literature remains constant in different ethnic groups; thus,
differences in publication do not reflect a difference of entity of the disease but
rather a different contribution to publications.
In South America the research group for the published articles is the same, and
the works represent mainly an evolution of the same study focusing on semen
analysis, metabolomics, infertility pathophysiology, and endocrinology.
The three most prevalent topics in North America and Asia underline an atten-
tion to study the evolution of the pathology in time even after treatment and to
evaluate if the outcomes of surgical treatment meet the standards for good practice.
Articles discussing endocrinology often evaluate testicular volume at diagnosis and
follow catch-up growth after surgery, trying to give an indication of the best timing
to prevent infertility. On the other side, the spectrum of topics in Europe reflects
poor attention to prevention of infertility and follow-up after surgery.
Of particular interest is that there is no increasing trend during the years despite
an increase in the trend of publications about overall causes of infertility and
medically assisted procreation. In fact in delivering a PubMed research, it appears
that publications about MAP are more than 30 times higher than those about
varicocele.
We must report the fact that Asia appears abundantly below average, but a
strong bias is given that the fact that many publications from China were in original
language [10–17].
The same applies to the correlation between undescended testes and infertility if
compared to the studies on cryptorchidism alone. Both associations between infertil-
ity and disease show a progressive percentage increase in the total number of studies.
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4. Final considerations
This research is intended as a warning to the countries worldwide: when talking
about fertility, it is right to give a couple the chance to access medically assisted
procreation; consequently, scientific studies to improve its outcomes are reason-
able. International reports are therefore necessary and should foster research with
increasing outcomes. More space should also be given to investigate and prevent
male fertility diseases starting from the pediatric age, especially when they might
impair the patient’s future fertile potential [18].
All those involved in the pediatric treatment area should be stimulated to act
toward this goal, and each country should bear the responsibility of promoting and
financing andrological screening campaigns. At the international level, there are still
few opportunities, in terms of funds and staff, for the adolescents to receive
andrological counseling. This is then the bottom line: Is medically assisted procre-
ation the cure to one or more diseases, or is it the answer to the lack of a social
support network?
When talking about couple infertility, male causes account for about 35–40%,
among these, varicocele figures as the first [19].
Thus collective interest, research efforts, and healthcare funding aim to study
couple infertility at the time of inability of procreation, correction of varicocele in
adult age, and medically assisted procreation. This choice is taken despite the
increased risk of chronic irreversible damage of treating varicocele and other pedi-
atric andrological diseases in adult age and despite the costs and risks of MAP with
the additional risk of failure of medically assisted procreation.
In conclusion, the research effort and the capital invested in prevention of
infertility are not balanced with respect to efforts and investments relied into
medical assisted procreation.
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